GSA Capital Partners’s Health Catalyst HCAT Stock Holding History

GSA Capital Partners’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$44K	Sell	34,532 -107,805	-76%	-$203K	﹤0.01%	1613
2025 Q4	$340K	Buy	+142,337	New	+$389K	0.03%	1100
2025 Q3	–	Sell	-108,383	Closed	-$409K	–	1837
2025 Q2	$409K	Buy	108,383 +15,812	+17%	+$62.2K	0.03%	1052
2025 Q1	$419K	Buy	+92,571	New	+$490K	0.04%	921
2024 Q4	–	Sell	-22,934	Closed	-$187K	–	1763
2024 Q3	$187K	Sell	22,934 -87,851	-79%	-$635K	0.01%	1423
2024 Q2	$708K	Buy	110,785 +99,616	+892%	+$639K	0.05%	745
2024 Q1	$84K	Sell	11,169 -28,685	-72%	-$262K	0.01%	1503
2023 Q4	$369K	Buy	+39,854	New	+$326K	0.03%	999
2023 Q1	–	Sell	-103,925	Closed	-$1.1M	–	1648
2022 Q4	$1.1M	Buy	+103,925	New	+$1M	0.14%	173
2022 Q3	–	Sell	-93,315	Closed	-$1.35M	–	1666
2022 Q2	$1.35M	Buy	+93,315	New	+$1.59M	0.2%	57

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

CDC Financial Chicago, Illinois $157M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return

PVM

Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GSA Capital Partners's HCAT Position: Q1 2026 in Review

GSA Capital Partners reduced its Health Catalyst (HCAT) stake by 76% in Q1 2026, selling an estimated $203K and leaving 34,532 shares worth $44K. The position accounts for ﹤0.01% of the portfolio, ranked #1613.

GSA Capital Partners first reported a position in HCAT in Q2 2022 and has held it in 10 quarters since. The position peaked at $1.35M in Q2 2022. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

GSA Capital Partners held 34,532 shares of Health Catalyst worth $44K as of Q1 2026.
GSA Capital Partners sold 107,805 Health Catalyst shares in Q1 2026, an estimated $203K.
Health Catalyst made up ﹤0.01% of GSA Capital Partners's portfolio in Q1 2026, its #1613 holding.
GSA Capital Partners first reported a position in Health Catalyst in Q2 2022 and has held it in 10 quarters since.
GSA Capital Partners's Health Catalyst position peaked at $1.35M in Q2 2022.
130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.